Daily Stock Analysis, GMED, Globus Medical Inc, priceseries

Globus Medical Inc. Daily Stock Analysis
Stock Information
Open
45.15
Close
45.80
High
46.08
Low
44.90
Previous Close
45.29
Daily Price Gain
0.51
YTD High
49.89
YTD High Date
Apr 1, 2019
YTD Low
38.01
YTD Low Date
Jan 3, 2019
YTD Price Change
6.19
YTD Gain
15.63%
52 Week High
57.83
52 Week High Date
Nov 8, 2018
52 Week Low
38.01
52 Week Low Date
Jan 3, 2019
52 Week Price Change
-6.24
52 Week Gain
-11.99%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 1. 2016
21.77
Jan 20. 2017
26.28
33 Trading Days
20.71%
Link
LONG
Jun 1. 2017
31.53
Jun 29. 2017
33.40
20 Trading Days
5.92%
Link
LONG
Nov 8. 2017
31.84
Dec 1. 2017
36.93
16 Trading Days
15.99%
Link
LONG
Mar 2. 2018
48.39
Mar 19. 2018
50.83
11 Trading Days
5.04%
Link
LONG
May 16. 2018
50.99
Jun 13. 2018
55.96
19 Trading Days
9.75%
Link
Company Information
Stock Symbol
GMED
Exchange
NYSE
Company URL
http://www.globusmedical.com
Company Phone
610-930-1800
CEO
David C. Paul
Headquarters
Pennsylvania
Business Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001237831
About

Globus Medical, Inc. is a medical device company, which focuses on developing products that promote healing in patients with musculoskeletal disorders. The company also focuses on products to treat patients with spine disorders. Its products fall into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products comprise fusion products to treat a wide variety of spinal disorders for the entire spine and can be used in a variety of surgical approaches. The Disruptive Technologies as those that represent a significant shift in the treatment of spinal disorders by allowing for novel surgical procedures, improvements to existing surgical procedures and the treatment of spinal disorders earlier in the continuum of care. Globus Medical was founded by David Paul, David M. Demski and David D. Davidar in March 2003 and is headquartered in Audubon, PA.

Description

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches. It provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. The company also offers various disruptive technology products that provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies comprising dynamic stabilization, total disc replacement, and interspinous process spacer products; regenerative biologics technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. In addition, it offers human tissue products, such as bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets. The company sells its implants and related disposables primarily to hospitals through direct sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.